Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Developing stabilized electrolytes solutions for disinfecting and antimicrobial applications

FY 2015-16

Summary
The most common disinfectants and cleaning agents used in medical applications are solutions comprised of sodium (or calcium) hypochlorite (i.e. bleach). On their own in aqueous solution, hypochlorites are generally unstable. In fact, under neutral or acidic conditions, in the presence of metal ions, or upon heating, hypochlorite can be hydrolyzed into hypochlorous acid, which quickly degrades into a mixture of chlorine, oxygen and other chlorates (as insoluble precipitates). Because of this instability, disinfecting solutions of diluted bleach are usually prepared fresh daily; both impractical and costly. However, one of the methods used to stabilize hypochlorite is to add basic water-soluble inorganic compounds. Pharmax Ltd. has been approached by some major players in the healthcare space, with the request to produce and deliver disinfecting/cleaning solutions for dialysis equipment. Dialysis equipment is particularly challenging to clean effectively owing to the tubing diameter, flow rates and mixed materials used in the machinery (plastics, metal, etc.). To this end, this research is focused on the development of a new bleach formulation that long term stability and reduced cost, when compared to other healthcare products on the market.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
478955-2015
Name nom
Koivisto, Bryan
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
507
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Industrial chemicals (solvents, resins)
Area of application fr
Produits chimiques industriels (solvants, résines)
Research subject code
3401
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Electrochemistry
Research subject fr
Électrochimie
Partie
1
Nb partie
1
Application title
Developing stabilized electrolytes solutions for disinfecting and antimicrobial applications
Keyword
NSERC
Application summary
The most common disinfectants and cleaning agents used in medical applications are solutions comprised of sodium (or calcium) hypochlorite (i.e. bleach). On their own in aqueous solution, hypochlorites are generally unstable. In fact, under neutral or acidic conditions, in the presence of metal ions, or upon heating, hypochlorite can be hydrolyzed into hypochlorous acid, which quickly degrades into a mixture of chlorine, oxygen and other chlorates (as insoluble precipitates). Because of this instability, disinfecting solutions of diluted bleach are usually prepared fresh daily; both impractical and costly. However, one of the methods used to stabilize hypochlorite is to add basic water-soluble inorganic compounds. Pharmax Ltd. has been approached by some major players in the healthcare space, with the request to produce and deliver disinfecting/cleaning solutions for dialysis equipment. Dialysis equipment is particularly challenging to clean effectively owing to the tubing diameter, flow rates and mixed materials used in the machinery (plastics, metal, etc.). To this end, this research is focused on the development of a new bleach formulation that long term stability and reduced cost, when compared to other healthcare products on the market.